AIMS: Cardiac stem cells (CSCs) show potential as a cellular therapeutic approach to blunt tissue damage and facilitate reparative and regenerative processes after myocardial infarction. Despite multiple published reports of improvement, functional benefits remain modest using normal stem cells delivered by adoptive transfer into damaged myocardium. The goal of this study is to enhance survival and proliferation of CSCs that have undergone lineage commitment in early phases as evidenced by expression of proteins driven by the alpha-myosin heavy chain (alphaMHC) promoter. The early increased expression of survival kinases augments expansion of the cardiogenic CSC pool and subsequent daughter progeny. MATERIALS & METHODS: Normal CSCs engineered with fluorescent reporter protein constructs under control of the alphaMHC promoter show transgene protein expression, confirming activity of the promoter in CSCs. Cultured CSCs from both nontransgenic and cardiac-specific transgenic mice expressing survival kinases driven by the alphaMHC promoter were analyzed to characterize transgene expression following treatments to promote differentiation in culture. RESULTS & CONCLUSION: Therapeutic genes controlled by the alphaMHC promoter can be engineered into and expressed in CSCs and cardiomyocyte progeny with the goal of improving the efficacy of cardiac stem cell therapy.
AIMS: Cardiac stem cells (CSCs) show potential as a cellular therapeutic approach to blunt tissue damage and facilitate reparative and regenerative processes after myocardial infarction. Despite multiple published reports of improvement, functional benefits remain modest using normal stem cells delivered by adoptive transfer into damaged myocardium. The goal of this study is to enhance survival and proliferation of CSCs that have undergone lineage commitment in early phases as evidenced by expression of proteins driven by the alpha-myosin heavy chain (alphaMHC) promoter. The early increased expression of survival kinases augments expansion of the cardiogenic CSC pool and subsequent daughter progeny. MATERIALS & METHODS: Normal CSCs engineered with fluorescent reporter protein constructs under control of the alphaMHC promoter show transgene protein expression, confirming activity of the promoter in CSCs. Cultured CSCs from both nontransgenic and cardiac-specific transgenic mice expressing survival kinases driven by the alphaMHC promoter were analyzed to characterize transgene expression following treatments to promote differentiation in culture. RESULTS & CONCLUSION: Therapeutic genes controlled by the alphaMHC promoter can be engineered into and expressed in CSCs and cardiomyocyte progeny with the goal of improving the efficacy of cardiac stem cell therapy.
Authors: John A Muraski; Kimberlee M Fischer; Weitao Wu; Christopher T Cottage; Pearl Quijada; Matt Mason; Shabana Din; Natalie Gude; Roberto Alvarez; Marcello Rota; Jan Kajstura; Zeping Wang; Erik Schaefer; Xiongen Chen; Scott MacDonnel; Nancy Magnuson; Stephen R Houser; Piero Anversa; Mark A Sussman Journal: Proc Natl Acad Sci U S A Date: 2008-09-10 Impact factor: 11.205
Authors: John A Muraski; Marcello Rota; Yu Misao; Jenna Fransioli; Christopher Cottage; Natalie Gude; Grazia Esposito; Francesca Delucchi; Michael Arcarese; Roberto Alvarez; Sailay Siddiqi; Gregory N Emmanuel; Weitao Wu; Kimberlee Fischer; Joshua J Martindale; Christopher C Glembotski; Annarosa Leri; Jan Kajstura; Nancy Magnuson; Anton Berns; Remus M Beretta; Steven R Houser; Erik M Schaefer; Piero Anversa; Mark A Sussman Journal: Nat Med Date: 2007-11-25 Impact factor: 53.440
Authors: Claudia Bearzi; Marcello Rota; Toru Hosoda; Jochen Tillmanns; Angelo Nascimbene; Antonella De Angelis; Saori Yasuzawa-Amano; Irina Trofimova; Robert W Siggins; Nicole Lecapitaine; Stefano Cascapera; Antonio P Beltrami; David A D'Alessandro; Elias Zias; Federico Quaini; Konrad Urbanek; Robert E Michler; Roberto Bolli; Jan Kajstura; Annarosa Leri; Piero Anversa Journal: Proc Natl Acad Sci U S A Date: 2007-08-20 Impact factor: 11.205
Authors: Zongjin Li; Andrew Lee; Mei Huang; Hyung Chun; Jaehoon Chung; Pauline Chu; Grant Hoyt; Phillip Yang; Jarrett Rosenberg; Robert C Robbins; Joseph C Wu Journal: J Am Coll Cardiol Date: 2009-04-07 Impact factor: 24.094
Authors: Jenna Fransioli; Brandi Bailey; Natalie A Gude; Christopher T Cottage; John A Muraski; Gregory Emmanuel; Weitao Wu; Roberto Alvarez; Marta Rubio; Sergio Ottolenghi; Erik Schaefer; Mark A Sussman Journal: Stem Cells Date: 2008-02-28 Impact factor: 6.277
Authors: Marcello Rota; M Elena Padin-Iruegas; Yu Misao; Antonella De Angelis; Silvia Maestroni; João Ferreira-Martins; Emanuela Fiumana; Raffaella Rastaldo; Michael L Arcarese; Thomas S Mitchell; Alessandro Boni; Roberto Bolli; Konrad Urbanek; Toru Hosoda; Piero Anversa; Annarosa Leri; Jan Kajstura Journal: Circ Res Date: 2008-06-12 Impact factor: 17.367
Authors: Joshua K Salabei; Pawel K Lorkiewicz; Candice R Holden; Qianhong Li; Kyung U Hong; Roberto Bolli; Aruni Bhatnagar; Bradford G Hill Journal: Stem Cells Date: 2015-05-26 Impact factor: 6.277
Authors: Mohsin Khan; Sadia Mohsin; Daniele Avitabile; Sailay Siddiqi; Jonathan Nguyen; Kathleen Wallach; Pearl Quijada; Michael McGregor; Natalie Gude; Roberto Alvarez; Douglas G Tilley; Walter J Koch; Mark A Sussman Journal: Circ Res Date: 2012-12-14 Impact factor: 17.367
Authors: Pearl Quijada; Nirmala Hariharan; Jonathan D Cubillo; Kristin M Bala; Jacqueline M Emathinger; Bingyan J Wang; Lucia Ormachea; Donald M Bers; Mark A Sussman; Coralie Poizat Journal: J Biol Chem Date: 2015-08-31 Impact factor: 5.157